Amarin Corporation is a biotechnology business based in the US. Amarin Corporation stocks (AMRN.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $4.45 – a decrease of 1.98% over the previous week. Amarin Corporation employs 1,000 staff and has a trailing 12-month revenue of around $601.2 million.
Since the stock market crash in March caused by coronavirus, Amarin Corporation's stock price has had significant negative movement.
Its last market close was $4.45, which is 75.18% down on its pre-crash value of $17.93 and 92.81% down on the lowest point reached during the March crash when the stocks fell as low as $8.58.
If you had bought $1,000 worth of Amarin Corporation stocks at the start of February 2020, those stocks would have been worth $573.71 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $241.99.
|Latest market close||$4.45|
|52-week range||$3.36 - $9.25|
|50-day moving average||$4.5557|
|200-day moving average||$5.6499|
|Wall St. target price||$10.13|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.002|
Note: The dollar amounts in the table below are in Canadian dollars.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
|1 month (2021-06-23)||-1.98%|
Valuing Amarin Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Amarin Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Amarin Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 2060x. In other words, Amarin Corporation stocks trade at around 2060x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the stocks or simply that they're over-valued.
Amarin Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$5.1 million.
The EBITDA is a measure of a Amarin Corporation's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$601.2 million|
|Operating margin TTM||0.51%|
|Gross profit TTM||USD$482.6 million|
|Return on assets TTM||0.2%|
|Return on equity TTM||0.15%|
|Market capitalisation||USD$1.6 billion|
TTM: trailing 12 months
There are currently 23.5 million Amarin Corporation stocks held short by investors – that's known as Amarin Corporation's "short interest". This figure is 6.1% down from 25.1 million last month.
There are a few different ways that this level of interest in shorting Amarin Corporation stocks can be evaluated.
Amarin Corporation's "short interest ratio" (SIR) is the quantity of Amarin Corporation stocks currently shorted divided by the average quantity of Amarin Corporation stocks traded daily (recently around 3.4 million). Amarin Corporation's SIR currently stands at 6.83. In other words for every 100,000 Amarin Corporation stocks traded daily on the market, roughly 6830 stocks are currently held short.
However Amarin Corporation's short interest can also be evaluated against the total number of Amarin Corporation stocks, or, against the total number of tradable Amarin Corporation stocks (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Amarin Corporation's short interest could be expressed as 0.06% of the outstanding stocks (for every 100,000 Amarin Corporation stocks in existence, roughly 60 stocks are currently held short) or 0.0655% of the tradable stocks (for every 100,000 tradable Amarin Corporation stocks, roughly 66 stocks are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the stock price, with fewer people currently willing to bet against Amarin Corporation.
Find out more about how you can short Amarin Corporation stock.
We're not expecting Amarin Corporation to pay a dividend over the next 12 months. However, you can browse other dividend-paying stocks in our guide.
Amarin Corporation stocks were split on a 1:10 basis on 18 January 2008. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Amarin Corporation stocks – just the quantity. However, indirectly, the new 900% higher stock price could have impacted the market appetite for Amarin Corporation stocks which in turn could have impacted Amarin Corporation's stock price.
Over the last 12 months, Amarin Corporation's stocks have ranged in value from as little as $3.36 up to $9.25. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a stocks volatility in relation to the market. The market (NASDAQ average) beta is 1, while Amarin Corporation's is 2.2421. This would suggest that Amarin Corporation's stocks are significantly more volatile than the average for this exchange and represent a higher risk.
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, and eicosapentaenoic acid. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
Everything we know about the Zevia PBC IPO, plus information on how to buy in.
Everything we know about the Xponential Fitness IPO, plus information on how to buy in.
Everything we know about the SOPHiA Genetics IPO, plus information on how to buy in.
Everything we know about the Ryan Specialty Group Holdings IPO, plus information on how to buy in.
Everything we know about the Ocean Biomedical IPO, plus information on how to buy in.
Everything we know about the Instructure Holdings IPO, plus information on how to buy in.
Everything we know about the Gambling.com Group IPO, plus information on how to buy in.
Everything we know about the Elicio Therapeutics IPO, plus information on how to buy in.
Everything we know about the Cytek Biosciences IPO, plus information on how to buy in.
Everything we know about the Core & Main IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.